Public Title Status Last Date Modified
EffectiveNess of VISanne® in Improving Quality of Life in asIan wOmen With eNdometriosis Ongoing 14 Jun 2018
Narrowband ultraviolet B phototherapy versus visible light in HIV pruritus: a randomized controlled trial . . . Ongoing 04 Oct 2017
A Double-Blind, Placebo-Controlled Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Ascending Dose and Multiple Doses of GSK3389404 in Chronic Hepatitis B Subj . . . Ongoing 18 Jan 2018
Phase 3, Randomized, double-blind, placebo-controlled, 26 week multicenter study to evaluate the efficacy and safety of Ertugliflozin in Asian Subjects with Type 2 Diabetes Mellitus and inadequate gly . . . Ongoing 17 Dec 2018
A Phase 3 Randomized, Double-Blind Study Assessing the Efficacy and Safety of PF-06438179 and Infliximab in Combination with Methotrexate in Subjects with Moderately to Severely Active Rheumatoid Art . . . Completed 18 Dec 2018
The impact of speech and lip reading training and adjustment counseling on the elderly individual’s ability to cope with mild sensorineural hearing loss . . . Completed 12 Feb 2016
An Observational Study on the Effects of Ballroom Dancing Filipino Elderly with Mild Cognitive Impairment . . . Ongoing 12 Feb 2016
Burden of Alzheimer’s Disease among Community Dwelling Filipino Community Ongoing 12 Feb 2016
Public health emergency SOLIDARITY TRIAL Ongoing 20 May 2020
PHASE 1,STUDY TO ASSESS THE PHARMACOKINETICS, SAFETY AND TOLERABILITY OF CEFTAZIDIMEAVIBACTAM (CAZ-AVI) IN CHILDREN FROM 3 MONTHS TO LESS THAN 18 YEARS OF AGE WHO ARE HOSPITALIZED AND RECEIVING SYSTE . . . Pending 09 Sep 2020
A multi-center, randomized, 12-week treatment, doubleblind study to assess the efficacy and safety of QMF149 (150/80 microgram) compared with MF Twisthaler® (200 microgram) in adult and adolesce . . . Completed 03 Mar 2020
Afatinib as second line therapy for lung cancer with Epidermal Growth Factor Receptor mutation. Completed 29 Nov 2018
A Phase III Randomized, Double Blind, Parallel Group, Placebo Controlled, Multi-centre, Multinational Study to Evaluate Efficacy and Safety of TRC150094 as an Add On to Standard of Care in Improving C . . . Ongoing 23 Oct 2018
A randomized, double-blind, placebo-controlled, phase III study evaluating the efficacy and safety of pembrolizumab plus platinum-based doublet chemotherapy with or without canakinumab as first lin . . . Ongoing 12 Aug 2020
A Randomized, Observer-blind, Placebo-controlled, Multicenter, Phase 3 Study to Assess the Efficacy, Safety, and Immunogenicity of a Plant-Derived Quadrivalent VLP Influenza Vaccine in Adults 18-64 . . . Completed 15 Oct 2018
A study to determine the safety and immunogenicity of a new Pneumococcal vaccine in healthy infants Pending 06 Feb 2018
A Two-Arm, Open-label, Randomized Phase III Study of Pembrolizumab (MK-3475)  Monotherapy versus Standard Chemotherapy in Platinum Pre-treated, Recurrent or Metastatic Nasopharyngeal Cancer (NPC) (K . . . Ongoing 25 Sep 2020
An open-label, multicenter, Phase IIIb study to assess the safety and efficacy of ribociclib (LEE011) in combination with letrozole for the treatment of men and pre/postmenopausal women with hormone . . . Ongoing 21 Nov 2017
Immunogenicity, reactogenicity and safety of a booster dose of MenACWY-TT vaccine (PF-06866681). Ongoing 21 Jul 2017
Imovax® Rabies and VERORAB® Immunogenicity and Safety after One Week 2-sites Intradermal or 1-site Intramuscular Pre-Exposure Prophylaxis Regimens, Followed by a Simulated Intradermal or Intramusc . . . Ongoing 02 Jul 2020
Methotrexate Withdrawal Study of Tofacitinib Modified Release Formulation in Subjects With Rheumatoid Arthritis   . . . Completed 19 Mar 2019
Reduced-dosed rivaroxaban in the long-term prevention of recurrent symptomatic VTE Ongoing 22 Dec 2014
Safety of Plasma Aβ1-42 and Aβ1-40 Reduction with H.E.A.L.E.R (Haemoadsorption for Extracorporeal Amyloid-β Level Expedited Reduction) using BETACLEAR BICARB 1000 in Healthy Elderly Individuals . . . Pending 04 Feb 2015
The long-term antibody persistence of MenACWY-TT vaccine (PF-06866681) versus Mencevax® ACWY in healthy adolescents and adults and booster response to MenACWY-TT vaccine administered at 10 years p . . . Completed 17 Jul 2019
The long-term antibody persistence of MenACWY-TT vaccine (PF-06866681) versus Mencevax® ACWY in healthy adolescents and adults and booster response to MenACWY-TT vaccine administered at 10 years p . . . Completed 17 Jul 2019

Copyright © One Window Project 2020. All rights reserved.